(Q46165787)

20 December 2017

title

Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression (English)

1 reference

20 December 2017

2

Akira Shimizu

1 reference

20 December 2017

author name string

Akiko Mii

1

1 reference

20 December 2017

Yukinari Masuda

3

1 reference

20 December 2017

Masamichi Ishizaki

4

1 reference

20 December 2017

Hiroshi Kawachi

5

1 reference

20 December 2017

Yasuhiko Iino

6

1 reference

20 December 2017

Yasuo Katayama

7

1 reference

20 December 2017

Yuh Fukuda

8

1 reference

20 December 2017

publication date

12 January 2009

1 reference

20 December 2017

published in

Laboratory Investigation

1 reference

20 December 2017

volume

89

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

164-177

1 reference

20 December 2017

The biochemistry of the renin-angiotensin system and its role in hypertension

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Renin-angiotensin system and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Renin-angiotensin-aldosterone system and progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Angiotensin II-induced reactive oxygen species and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Effect of angiotensin II antagonism on the regression of kidney disease in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Histological grading and staging of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Grading of acute and chronic renal lesions in Henoch-Schönlein purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

IFN-inducible protein-10 plays a pivotal role in maintaining slit-diaphragm function by regulating podocyte cell-cycle balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Update on tissue renin-angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Effects of KD3-671, an angiotensin II type 1 receptor antagonist, on anti-thy-1 nephritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Local actions of endogenous angiotensin II in injured glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Angiogenesis and endothelial cell repair in renal disease and allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Apoptosis in the repair process of experimental proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Complement-mediated killing of mesangial cells in experimental glomerulonephritis: cell death by a combination of apoptosis and necrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Podocyte injuries exacerbate mesangial proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Angiotensin II receptor blockade ameliorates mesangioproliferative glomerulonephritis in rats through suppression of CTGF and PAI-1, independently of the coagulation system

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

Drug targeting using OX7-immunoliposomes: correlation between Thy1.1 antigen expression and tissue distribution in the rat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.128

7 January 2021

10.1038/LABINVEST.2008.128

Identifiers

DOI

1 reference

20 December 2017

Dimensions Publication ID

1031757731

0 references

1 reference

20 December 2017